Regeneron Pharmaceuticals has settled allegations that it misused a patented protein to test its COVID-19 treatment REGEN-COV ...

Pfizer's 2025 guidance to be revealed Tuesday. Goldman Sachs predicts $64.9 billion revenue and EPS of $3.13, supported by ...

Pfizer just raised its dividend by 2.4% to $0.43, giving investors something to cheer about despite the stock’s lackluster ...

Pfizer's shares have significantly underperformed, but the current valuation and high dividend yield present a compelling ...

With a market capitalization of more than $143 billion today, Pfizer (NYSE: PFE) stock won't make anyone into a millionaire ...

Pfizer Inc.'s ( NYSE:PFE) periodic dividend will be increasing on the 7th of March to $0.43, with investors receiving 2.4% ...

The efficacy data could help cushion Ibrance's losses of market share to Kisqali, a similar drug from Novartis.

CHARLESTON, W.Va. — West Virginia Attorney General Patrick Morrisey on Thursday said the Circuit Court of Mason County has approved a settlement between the state and pharmaceutical companies Pfizer ...

Pfizer has a diversified portfolio, including successful vaccines and promising new drugs. Read more to see why I upgrade PFE ...

SAN DIEGO — Pfizer’s abrupt withdrawal of its sickle cell drug Oxybryta over safety concerns was called “tone deaf” during a ...

Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on ...

Today, Benzinga 's options scanner spotted 29 uncommon options trades for Pfizer. This isn't normal. The overall sentiment of ...